Mizuho Securities analyst Salim Syed reiterated a Neutral rating and $212.00 price target on Amgen (NASDAQ: AMGN) following Mirati's ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE